News Release


 

Taiho and Meiji Enter Into a Co-marketing Agreement in Japan for TAC-202(bilastine), a Treatment for Allergic Disorders (17/12/2015)

http://www.taiho.co.jp/english/news/pdf/20151217.pdf


<< Back